JR Exequiel Pineda
- Assistant Clinical Professor, Medicine - (Clinical Series Track)
- (520) 626-6453
- Sarver Heart Center, Rm. 2301
- Tucson, AZ 85724
- jretpineda@arizona.edu
Biography
Dr. Pineda is a clinical assistant professor at the University of Arizona Sarver Heart Center and an interventional cardiologist at Banner-University Medical Center Tucson (North and South Campus).
He is board certified in internal medicine, cardiovascular disease, interventional cardiology and echocardiography and board eligible in vascular medicine.
Dr. Pineda earned his combined MD-PhD at the Albert Einstein College of Medicine with a research focus on computational biophysical studies of ligand binding and catalysis by enzymes. He completed his internal medicine residency at the Cleveland Clinic Foundation (CCF) in Cleveland, Ohio, followed by a clinical fellowship in vascular medicine, also at CCF. He then completed a fellowship in cardiovascular disease at the University of Arizona and a research fellowship at Banner-University Medical Center in Tucson, after which he then completed an interventional cardiology fellowship at the University of Arizona.
His clinical interests include:
Preventative cardiology
Cardiovascular care of patients with cancer who develop cardiovascular toxicities from their treatment
Hypertrophic cardiomyopathy
Interventional cardiology
Research Interests:
Dr. Pineda's research interests include ligand binding to the thin filament through computational biophysical (in silico) studies and validation by in vitro and in vivo experiments to understand the cardiotoxic effects of some chemotherapeutics.
Dr. Pineda is also actively involved in organizing cardiac simulation modules using the VIST G5 and G7 endovascular simulators to further develop the clinical competencies of medical trainees.
Degrees
- Medical Scientist Training Program MD-PhD
- Albert Einstein College of Medicine, New York, New York, United States
- Doctoral Dissertation:Multiple-Time-Scale Dynamics in Enzyme Catalysis Major Field(s):Computational Biophysics, Theoretical Enzymology
Awards
- Best CCU Attending for Academic Year 2023-2024
- University of Arizona Sarver Heart Center, Summer 2024
Licensure & Certification
- Internal Medicine, American Board of Internal Medicine (2014)
- Medical License, Arizona Medical Board (2018)
- Interventional Cardiology, American Board of Internal Medicine (2020)
- Cardiovascular Disease, American Board of Internal Medicine (2019)
- Adult Echocardiography Certification, National Board of Echocardiography (2021)
Interests
No activities entered.
Courses
2023-24 Courses
-
Clinical Cardiology
MEDI 850A (Fall 2023) -
Coronary Care Unit
MEDI 840C (Fall 2023)
2022-23 Courses
-
Clinical Cardiology
MEDI 850A (Fall 2022)
2021-22 Courses
-
Clinical Cardiology
MEDI 850A (Fall 2021)
2020-21 Courses
-
Clinical Cardiology
MEDI 850A (Spring 2021)
Scholarly Contributions
Journals/Publications
- Tan, M. C., Yeo, Y. H., Ang, Q. X., Lee, J. Z., Yang, E. H., Mazzarelli, J. K., Pineda, J. E., Su, W., & Lee, K. S. (2024). Hospital Outcomes of Spontaneous Coronary Artery Dissection With Concurrent Ventricular Arrhythmias. Journal of the Society for Cardiovascular Angiography & Interventions, 3(3Part A), 101231.More infoWhile patients with spontaneous coronary artery dissection (SCAD) occasionally present with concurrent ventricular arrhythmias (VA), the impact of VA on in-hospital outcomes in the United States (US) is not well-established. This study aims to analyze in-hospital outcomes of patients with SCAD and concurrent VA and to determine the factors associated with VA occurrence in this high-risk population in the US.
- Pineda, J. R., Kim, E. S., & Osinbowale, O. O. (2022). Impact of pharmacologic interventions on peripheral artery disease. Progress in cardiovascular diseases, 57(5), 510-20.More infoPharmacologic interventions are an integral component of peripheral artery disease (PAD) management, supported by high-quality clinical studies. Those affected by this potentially debilitating and life-threatening disease process often have multiple contributing conditions, such as tobacco abuse, diabetes, hypertension, and hyperlipidemia. In addition to medications aimed at improving claudication symptoms, risk factor modification and appropriate use of antiplatelet agents are essential to decreasing rates of major adverse clinical events and improving vessel patency following intervention. While lower extremity PAD is increasingly recognized as a prevalent condition, affected individuals remain undertreated with optimal pharmacotherapy. Novel approaches to treatment of PAD include stem cell therapy, which may play a beneficial role in those with minimal revascularization options but disease placing them at high risk for limb amputation. Additionally, timely initiation of optimal pharmacotherapy represents a cost-effective approach to management of this chronic condition.
- Seckeler, M. D., Pineda, J. R., & Lotun, K. (2021). Successful Transcatheter Recanalization of a Chronically Occluded Left Pulmonary Artery Due to Fibrosing Mediastinitis. JACC. Cardiovascular interventions, 14(16), e215-e216.
- Shanmugasundaram, M., Pineda, J. E., & Murugapandian, S. (2021). Glucose-Lowering Medications and Cardiovascular outcomes. Current Cardiology Reports.
Presentations
- Pineda, J. E. (2024, July). Stable Ischemic Heart disease. Fellows Core Conference. Tucson, AZ: University of Arizona College of Medicine.
- Pineda, J. E. (2024, July).
. Cardiology Fellowship Core Conference. Tucson, AZ: The University of Arizona College of Medicine.Stable Ischemic Heart disease - Pineda, J. E. (2024, June). Interventional Cardio-oncology – Recent Update. CITIC 2024. Congress, Mexico City: Cardiovascular Imaging, Technology and Intervention Course.
- Pineda, J. E. (2024, November). Simulation for the Future of Interventional Cardiology Education. The 15th CIAT Annual Scientific Conference 2024 Session on Future Trends in Interventional Cardiology. Bangkok, Thailand: The Cardiovascular Intervention Association of Thailand.
- Pineda, J. E. (2024, September). Interventional Cardio oncology. Fellows Core Conference. Tucson, AZ: University of Arizona College of Medicine, Tucson.
- Pineda, J. E. (2024, September).
. Cardiology Fellowship Core Conference. Tucson, AZ: The University of Arizona College of Medicine.EBM/Biostats - Seckeler, M., Pineda, J. E., & Lotun, K. (2020, March). Recanalization of a Chronically Occluded Left Pulmonary Artery Due to Fibrosing Mediastinitis. American College of Cardiology 69th Annual Scientific Session/World Congress of Cardiology. Chicago, IL.More infoOral presentation of interesting case. Conference cancelled due to COVID-19 pandemic.
